Metastatic Prostate Cancer Treatment  Market Report

Global Metastatic Prostate Cancer Treatment Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 08, 2022
  • PAGES：136
  • REPORT CODE：GMM840859
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Metastatic Prostate Cancer Treatment market report explains the definition, types, applications, major countries, and major players of the Metastatic Prostate Cancer Treatment market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • BeiGene

    • Immunomedics(Gilead Sciences Inc)

    • Zenith Epigenetics Ltd

    • VasGene Therapeutics Inc

    • Telix Pharmaceuticals

    • Arvinas Inc

    • SeleXel

    • eFFECTOR Therapeutics

    • Amgen

    • Genentech

    • AB Science

    • Myovant Biosciences

    By Type:

    • Mono

    • Combination

    • Mono/Combination

    By End-User:

    • Hospital

    • Drug Store

    • Online Pharmacy

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Metastatic Prostate Cancer Treatment Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Metastatic Prostate Cancer Treatment Outlook to 2028- Original Forecasts

    • 2.2 Metastatic Prostate Cancer Treatment Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Metastatic Prostate Cancer Treatment Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Metastatic Prostate Cancer Treatment Market- Recent Developments

    • 6.1 Metastatic Prostate Cancer Treatment Market News and Developments

    • 6.2 Metastatic Prostate Cancer Treatment Market Deals Landscape

    7 Metastatic Prostate Cancer Treatment Raw Materials and Cost Structure Analysis

    • 7.1 Metastatic Prostate Cancer Treatment Key Raw Materials

    • 7.2 Metastatic Prostate Cancer Treatment Price Trend of Key Raw Materials

    • 7.3 Metastatic Prostate Cancer Treatment Key Suppliers of Raw Materials

    • 7.4 Metastatic Prostate Cancer Treatment Market Concentration Rate of Raw Materials

    • 7.5 Metastatic Prostate Cancer Treatment Cost Structure Analysis

      • 7.5.1 Metastatic Prostate Cancer Treatment Raw Materials Analysis

      • 7.5.2 Metastatic Prostate Cancer Treatment Labor Cost Analysis

      • 7.5.3 Metastatic Prostate Cancer Treatment Manufacturing Expenses Analysis

    8 Global Metastatic Prostate Cancer Treatment Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Metastatic Prostate Cancer Treatment Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Metastatic Prostate Cancer Treatment Export by Region (Top 10 Countries) (2017-2028)

    9 Global Metastatic Prostate Cancer Treatment Market Outlook by Types and Applications to 2022

    • 9.1 Global Metastatic Prostate Cancer Treatment Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Mono Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Combination Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Mono/Combination Consumption and Growth Rate (2017-2022)

    • 9.2 Global Metastatic Prostate Cancer Treatment Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Drug Store Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Metastatic Prostate Cancer Treatment Market Analysis and Outlook till 2022

    • 10.1 Global Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.2.2 Canada Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.2.3 Mexico Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.2 UK Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.3 Spain Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.4 Belgium Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.5 France Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.6 Italy Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.7 Denmark Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.8 Finland Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.9 Norway Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.10 Sweden Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.11 Poland Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.12 Russia Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.3.13 Turkey Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.2 Japan Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.3 India Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.4 South Korea Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.5 Pakistan Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.6 Bangladesh Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.7 Indonesia Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.8 Thailand Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.9 Singapore Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.10 Malaysia Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.11 Philippines Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.4.12 Vietnam Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.5.2 Colombia Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.5.3 Chile Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.5.4 Argentina Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.5.5 Venezuela Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.5.6 Peru Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.5.7 Puerto Rico Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.5.8 Ecuador Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.6.2 Kuwait Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.6.3 Oman Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.6.4 Qatar Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.7.2 South Africa Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.7.3 Egypt Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.7.4 Algeria Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Metastatic Prostate Cancer Treatment Consumption (2017-2022)

      • 10.8.2 New Zealand Metastatic Prostate Cancer Treatment Consumption (2017-2022)

    11 Global Metastatic Prostate Cancer Treatment Competitive Analysis

    • 11.1 BeiGene

      • 11.1.1 BeiGene Company Details

      • 11.1.2 BeiGene Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 BeiGene Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.1.4 BeiGene Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Immunomedics(Gilead Sciences Inc)

      • 11.2.1 Immunomedics(Gilead Sciences Inc) Company Details

      • 11.2.2 Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.2.4 Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Zenith Epigenetics Ltd

      • 11.3.1 Zenith Epigenetics Ltd Company Details

      • 11.3.2 Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.3.4 Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 VasGene Therapeutics Inc

      • 11.4.1 VasGene Therapeutics Inc Company Details

      • 11.4.2 VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.4.4 VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Telix Pharmaceuticals

      • 11.5.1 Telix Pharmaceuticals Company Details

      • 11.5.2 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.5.4 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Arvinas Inc

      • 11.6.1 Arvinas Inc Company Details

      • 11.6.2 Arvinas Inc Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Arvinas Inc Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.6.4 Arvinas Inc Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 SeleXel

      • 11.7.1 SeleXel Company Details

      • 11.7.2 SeleXel Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 SeleXel Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.7.4 SeleXel Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 eFFECTOR Therapeutics

      • 11.8.1 eFFECTOR Therapeutics Company Details

      • 11.8.2 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.8.4 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 Amgen

      • 11.9.1 Amgen Company Details

      • 11.9.2 Amgen Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 Amgen Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.9.4 Amgen Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Genentech

      • 11.10.1 Genentech Company Details

      • 11.10.2 Genentech Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Genentech Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.10.4 Genentech Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 AB Science

      • 11.11.1 AB Science Company Details

      • 11.11.2 AB Science Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 AB Science Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.11.4 AB Science Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 Myovant Biosciences

      • 11.12.1 Myovant Biosciences Company Details

      • 11.12.2 Myovant Biosciences Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Main Business and Markets Served

      • 11.12.4 Myovant Biosciences Metastatic Prostate Cancer Treatment Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    12 Global Metastatic Prostate Cancer Treatment Market Outlook by Types and Applications to 2028

    • 12.1 Global Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Mono Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Combination Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Mono/Combination Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Metastatic Prostate Cancer Treatment Market Analysis and Outlook to 2028

    • 13.1 Global Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.2.2 Canada Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.2 UK Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.3 Spain Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.5 France Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.6 Italy Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.8 Finland Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.9 Norway Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.11 Poland Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.12 Russia Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.2 Japan Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.3 India Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.5.3 Chile Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.5.6 Peru Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.6.3 Oman Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Metastatic Prostate Cancer Treatment Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Metastatic Prostate Cancer Treatment

    • Figure of Metastatic Prostate Cancer Treatment Picture

    • Table Global Metastatic Prostate Cancer Treatment Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Metastatic Prostate Cancer Treatment Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Mono Consumption and Growth Rate (2017-2022)

    • Figure Global Combination Consumption and Growth Rate (2017-2022)

    • Figure Global Mono/Combination Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Drug Store Consumption and Growth Rate (2017-2022)

    • Figure Global Online Pharmacy Consumption and Growth Rate (2017-2022)

    • Figure Global Metastatic Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Table North America Metastatic Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Figure United States Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Canada Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Mexico Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table Europe Metastatic Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Figure Germany Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure UK Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Spain Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Belgium Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure France Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Italy Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Denmark Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Finland Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Norway Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Sweden Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Poland Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Russia Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Turkey Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table APAC Metastatic Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Figure China Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Japan Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure India Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Korea Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Thailand Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Singapore Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Philippines Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table South America Metastatic Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Figure Brazil Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Colombia Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Chile Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Argentina Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Peru Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table GCC Metastatic Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Figure Bahrain Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Oman Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Qatar Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table Africa Metastatic Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Figure Nigeria Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure South Africa Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Egypt Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure Algeria Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table Oceania Metastatic Prostate Cancer Treatment Consumption by Country (2017-2022)

    • Figure Australia Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Metastatic Prostate Cancer Treatment Consumption and Growth Rate (2017-2022)

    • Table BeiGene Company Details

    • Table BeiGene Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table BeiGene Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table BeiGene Metastatic Prostate Cancer Treatment Product Portfolio

    • Table Immunomedics(Gilead Sciences Inc) Company Details

    • Table Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table Immunomedics(Gilead Sciences Inc) Metastatic Prostate Cancer Treatment Product Portfolio

    • Table Zenith Epigenetics Ltd Company Details

    • Table Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table Zenith Epigenetics Ltd Metastatic Prostate Cancer Treatment Product Portfolio

    • Table VasGene Therapeutics Inc Company Details

    • Table VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table VasGene Therapeutics Inc Metastatic Prostate Cancer Treatment Product Portfolio

    • Table Telix Pharmaceuticals Company Details

    • Table Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product Portfolio

    • Table Arvinas Inc Company Details

    • Table Arvinas Inc Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arvinas Inc Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table Arvinas Inc Metastatic Prostate Cancer Treatment Product Portfolio

    • Table SeleXel Company Details

    • Table SeleXel Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table SeleXel Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table SeleXel Metastatic Prostate Cancer Treatment Product Portfolio

    • Table eFFECTOR Therapeutics Company Details

    • Table eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product Portfolio

    • Table Amgen Company Details

    • Table Amgen Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Amgen Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table Amgen Metastatic Prostate Cancer Treatment Product Portfolio

    • Table Genentech Company Details

    • Table Genentech Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Genentech Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table Genentech Metastatic Prostate Cancer Treatment Product Portfolio

    • Table AB Science Company Details

    • Table AB Science Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table AB Science Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table AB Science Metastatic Prostate Cancer Treatment Product Portfolio

    • Table Myovant Biosciences Company Details

    • Table Myovant Biosciences Metastatic Prostate Cancer Treatment Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myovant Biosciences Metastatic Prostate Cancer Treatment Main Business and Markets Served

    • Table Myovant Biosciences Metastatic Prostate Cancer Treatment Product Portfolio

    • Figure Global Mono Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Combination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Mono/Combination Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Drug Store Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Online Pharmacy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Metastatic Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Table North America Metastatic Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure United States Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Metastatic Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure Germany Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Metastatic Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure China Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Metastatic Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure Brazil Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Metastatic Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Metastatic Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Metastatic Prostate Cancer Treatment Consumption Forecast by Country (2022-2028)

    • Figure Australia Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Metastatic Prostate Cancer Treatment Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US